Summary of Inventories, net of reserves |
Inventories were as follows (in thousands): | | | | | | | | | August 31, 2022 | | May 31, 2022 | Raw materials | | $ | 16,264 | | $ | 16,264 | Work-in-progress | | | 1,665 | | | 1,665 | Total inventories, net | | $ | 17,929 | | $ | 17,929 |
|
Schedule of remaining shelf life of inventory |
| | | | | | | | | | | | | | | | | | | | | | | | Raw Materials | | | Work-in-progress | | | | (in thousands, Expiration period ending August 31,) | | Remaining shelf-life (mos) | | Specialized | | Resins | | Other | | Total Raw Materials | | Bulk drug product | | Finished drug product | | Total inventories | 2023 | | 0 to 12 | $ | 3,658 | $ | - | $ | 1,421 | $ | 5,079 | | $ | 1,824 | | $ | - | | $ | 6,903 | 2024 | | 13 to 24 | | 682 | | 16,264 | | 1,590 | | 18,536 | | | 1,665 | | | - | | | 20,201 | 2025 | | 25 to 36 | | 2,099 | | - | | - | | 2,099 | | | - | | | 29,142 | | | 31,241 | 2026 | | 37 to 48 | | 3,435 | | - | | - | | 3,435 | | | - | | | 32,344 | | | 35,779 | Thereafter | | 49 or more | | - | | - | | - | | - | | | - | | | - | | | - | Inventories, gross | | | | 9,874 | | 16,264 | | 3,011 | | 29,149 | | | 3,489 | | | 61,486 | | | 94,124 | Inventory charge | | | | (9,874) | | - | | (3,011) | | (12,885) | | | (1,824) | | | (61,486) | | | (76,195) | Inventories, net | | | $ | - | $ | 16,264 | $ | - | $ | 16,264 | | $ | 1,665 | | $ | - | | $ | 17,929 |
|